NFAT Induces Breast Cancer Cell Invasion by Promoting the Induction of Cyclooxygenase-2*

The NFAT (nuclear factor of activated T cells) family of transcription factors plays a fundamental role in the transcriptional regulation of the immune response. However, NFATs are ubiquitously expressed, and recent evidence points to their important functions in human epithelial cells and carcinomas. Specifically, NFAT has been shown to be active in human breast and colon carcinoma cells and to promote their invasion through Matrigel. The mechanisms by which NFAT promotes invasion have not been defined. To identify NFAT target genes that induce carcinoma invasion, we have established stable breast cancer cell lines that inducibly express transcriptionally active NFAT. Gene expression profiling by cDNA microarray of cells induced to express NFAT revealed up-regulation of cyclooxygenase-2 (COX-2). Increased NFAT expression and activity induced COX-2 expression as well as prostaglandin E2 synthesis. This induction was more prominent when NFAT was activated by phorbol 12-myristate 13-acetate and calcium ionophore ionomycin and was blocked by the NFAT antagonist cyclosporin A. Breast cancer cells with elevated COX-2 expression showed increased invasion through Matrigel, and this was reduced in cells treated with COX-2 inhibitors. Conversely, loss of NFAT1 protein expression using small interfering RNA led to a reduction in COX-2 transcription and reduced invasion. Similarly, Matrigel invasion was reduced in cells in which COX-2 expression was reduced using specific siRNA. These findings demonstrate that NFAT promotes breast cancer cell invasion through the induction of COX-2 and the synthesis of prostaglandins.

[1]  G. Crabtree,et al.  Identification of a putative regulator of early T cell activation genes. , 1988, Science.

[2]  G. Crabtree,et al.  Characterization of antigen receptor response elements within the interleukin-2 enhancer , 1988, Molecular and cellular biology.

[3]  L. Marnett,et al.  Prostaglandin and thromboxane biosynthesis. , 1991, Pharmacology & therapeutics.

[4]  A. Rao,et al.  Analysis of the preexisting and nuclear forms of nuclear factor of activated T cells. , 1993, Journal of immunology.

[5]  A. Ristimäki,et al.  Cyclooxygenase Gene Expression in Inflammation and Angiogenesis a , 1993, Annals of the New York Academy of Sciences.

[6]  T. Curran,et al.  The T-cell transcription factor NFATp is a substrate for calcineurin and interacts with Fos and Jun , 1993, Nature.

[7]  P. Hogan,et al.  Immunosuppressive drugs prevent a rapid dephosphorylation of transcription factor NFAT1 in stimulated immune cells. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[8]  R. DuBois,et al.  Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2 , 1995, Cell.

[9]  A. Rao,et al.  Calcineurin Binds the Transcription Factor NFAT1 and Reversibly Regulates Its Activity (*) , 1996, The Journal of Biological Chemistry.

[10]  R. DuBois,et al.  Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[11]  P. Hogan,et al.  Transcription factors of the NFAT family: regulation and function. , 1997, Annual review of immunology.

[12]  S. Shapiro,et al.  Nonsteroidal antiinflammatory drug use and reduced risk of large bowel carcinoma , 1998, Cancer.

[13]  M. Taketo,et al.  Size- and invasion-dependent increase in cyclooxygenase 2 levels in human colorectal carcinomas. , 1998, Cancer research.

[14]  K. Seibert,et al.  Chemopreventive activity of celecoxib, a specific cyclooxygenase-2 inhibitor, against colon carcinogenesis. , 1998, Cancer research.

[15]  R. DuBois,et al.  The role of cyclooxygenases in inflammation, cancer, and development , 1999, Oncogene.

[16]  N. Copeland,et al.  NF-AT5: the NF-AT family of transcription factors expands in a new direction. , 1999, Cold Spring Harbor symposia on quantitative biology.

[17]  F. Berberich-Siebelt,et al.  The role of NF-AT transcription factors in T cell activation and differentiation. , 2000, Biochimica et biophysica acta.

[18]  B. Levin,et al.  The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis. , 2000, The New England journal of medicine.

[19]  J. Masferrer,et al.  COX‐2 is expressed in human pulmonary, colonic, and mammary tumors , 2000, Cancer.

[20]  J. Qin,et al.  Concerted dephosphorylation of the transcription factor NFAT1 induces a conformational switch that regulates transcriptional activity. , 2000, Molecular cell.

[21]  R. Garavito,et al.  Cyclooxygenases: structural, cellular, and molecular biology. , 2000, Annual review of biochemistry.

[22]  V. Steele,et al.  Chemoprevention of colon cancer by specific cyclooxygenase-2 inhibitor, celecoxib, administered during different stages of carcinogenesis. , 2000, Cancer research.

[23]  J. Redondo,et al.  An Essential Role of the Nuclear Factor of Activated T Cells in the Regulation of the Expression of the Cyclooxygenase-2 Gene in Human T Lymphocytes* , 2000, The Journal of Biological Chemistry.

[24]  A. Rao,et al.  Partners in transcription: NFAT and AP-1 , 2001, Oncogene.

[25]  S. Sasayama,et al.  Calcineurin-GATA4 Pathway Is Involved in β-Adrenergic Agonist-responsive Endothelin-1 Transcription in Cardiac Myocytes* , 2001, The Journal of Biological Chemistry.

[26]  Rajnish A. Gupta,et al.  Colorectal cancer prevention and treatment by inhibition of cyclooxygenase-2 , 2001, Nature Reviews Cancer.

[27]  L. Marnett,et al.  COX-2: a target for colon cancer prevention. , 2002, Annual review of pharmacology and toxicology.

[28]  J. Decaprio,et al.  NFATc2-mediated repression of cyclin-dependent kinase 4 expression. , 2002, Molecular cell.

[29]  J. Viola,et al.  NFATC2 transcription factor regulates cell cycle progression during lymphocyte activation: evidence of its involvement in the control of cyclin gene expression , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[30]  C. Denkert,et al.  Expression of cyclooxygenase 2 is an independent prognostic factor in human ovarian carcinoma. , 2002, The American journal of pathology.

[31]  Leslie M. Shaw,et al.  The role of NFAT transcription factors in integrin-mediated carcinoma invasion , 2002, Nature Cell Biology.

[32]  A. Sahin,et al.  Cyclooxygenase-2 expression in human breast cancers and adjacent ductal carcinoma in situ. , 2002, Cancer research.

[33]  Fan Wang,et al.  Neurotrophins and Netrins Require Calcineurin/NFAT Signaling to Stimulate Outgrowth of Embryonic Axons , 2003, Cell.

[34]  E. Wagner,et al.  AP-1: a double-edged sword in tumorigenesis , 2003, Nature Reviews Cancer.

[35]  K. Subbaramaiah,et al.  Cyclooxygenase 2: a molecular target for cancer prevention and treatment. , 2003, Trends in pharmacological sciences.

[36]  Garret A. FitzGerald,et al.  COX-2 and beyond: approaches to prostaglandin inhibition in human disease , 2003, Nature Reviews Drug Discovery.

[37]  H. Okamura,et al.  Ca2+/calcineurin signalling in cells of the immune system. , 2003, Biochemical and biophysical research communications.

[38]  R. Brueggemeier,et al.  Prostaglandin E2 regulates aromatase activity and expression in human adipose stromal cells via two distinct receptor subtypes. , 2003, The Journal of clinical endocrinology and metabolism.

[39]  J. Kleibeuker,et al.  Non-steroidal anti-inflammatory drugs and molecular carcinogenesis of colorectal carcinomas , 2003, The Lancet.

[40]  Lin Chen,et al.  Transcriptional regulation by calcium, calcineurin, and NFAT. , 2003, Genes & development.

[41]  J. Neal,et al.  A Constitutively Active NFATc1 Mutant Induces a Transformed Phenotype in 3T3-L1 Fibroblasts* , 2003, The Journal of Biological Chemistry.

[42]  J. Redondo,et al.  Cyclooxygenase-2: a therapeutic target in angiogenesis. , 2003, Trends in molecular medicine.

[43]  Stephen P. Ethier,et al.  SUM-159PT cells: a novel estrogen independent human breast cancer model system , 1999, Breast Cancer Research and Treatment.

[44]  H. Joensuu,et al.  Association of cyclooxygenase-2 and matrix metalloproteinase-2 expression in human breast cancer , 2005, Breast Cancer Research and Treatment.

[45]  T. Hla,et al.  Role of prostaglandin E2-dependent angiogenic switch in cyclooxygenase 2-induced breast cancer progression. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[46]  S. Ashley,et al.  Prostaglandin E2 Enhances Pancreatic Cancer Invasiveness through an Ets-1-Dependent Induction of Matrix Metalloproteinase-2 , 2004, Cancer Research.

[47]  Emelyn H. Shroff,et al.  Nuclear Factor of Activated T Cells Balances Angiogenesis Activation and Inhibition , 2004, The Journal of experimental medicine.

[48]  Min Chen,et al.  Integrin α6β4 promotes expression of autotaxin/ENPP2 autocrine motility factor in breast carcinoma cells , 2005, Oncogene.

[49]  R. Cardiff,et al.  HER2/neu-induced mammary tumorigenesis and angiogenesis are reduced in cyclooxygenase-2 knockout mice. , 2005, Cancer research.

[50]  K. Druey,et al.  Prostaglandin E2 Promotes Colon Cancer Cell Growth Through a Gs-Axin-ß-Catenin Signaling Axis , 2005, Science.

[51]  A large cohort study of aspirin and other nonsteroidal anti-inflammatory drugs and prostate cancer incidence , 2005 .

[52]  M. Fresno,et al.  Expression and Function of the Nuclear Factor of Activated T Cells in Colon Carcinoma Cells , 2005, Journal of Biological Chemistry.

[53]  T. Hla,et al.  The prostaglandin E2 receptor EP2 is required for cyclooxygenase 2-mediated mammary hyperplasia. , 2005, Cancer research.

[54]  Chunxiang Zhang,et al.  Blockade of Nuclear Factor of Activated T Cells Activation Signaling Suppresses Balloon Injury-induced Neointima Formation in a Rat Carotid Artery Model* , 2005, Journal of Biological Chemistry.

[55]  Chad A. Corcoran,et al.  Cyclooxygenase-2 interacts with p53 and interferes with p53-dependent transcription and apoptosis , 2005, Oncogene.

[56]  P. Sismondi,et al.  Breast cancer and sex steroids: Critical review of epidemiological, experimental and clinical investigations on etiopathogenesis, chemoprevention and endocrine treatment of breast cancer , 2005, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.